AIDS—an approach for targeting HIV reservoirs

AIDS -- an approach for targeting HIV reservoirs
Schematic representation of CD4 T lymphocytes (in purple). Left: the CD4 T lymphocyte with significant metabolic activity is infected with HIV (in green). Right: the CD4 T lymphocyte has no metabolic activity and therefore cannot be infected. Credit: © Institut Pasteur / Nicolas Huot

Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus—it is their metabolic (or energy-producing) activity that enables the virus to multiply. Thanks to metabolic activity inhibitors, the researchers have managed to destroy these infected cells, or "reservoirs," ex vivo. Their findings were published in the journal Cell Metabolism on December 20, 2018.

The antiretroviral treatment used today is designed to block HIV infection but it is not able to eliminate the virus from the body. The virus remains in reservoirs—the CD4 T lymphocyte , the main targets of HIV. However, the virus does not infect all types of CD4 cell and until now the reason for this was not well known. In this study, scientists from the HIV, Inflammation and Persistence Unit at the Institut Pasteur and colleagues have identified the characteristics of the different CD4 subpopulations, which are associated with HIV infection.

The more the CD4 cells are differentiated, or experienced, the more they need to produce energy to perform their function. Experiments have shown that it is the metabolic activity of the cell, and in particular its glucose consumption, that plays a key role in susceptibility to HIV infection. The virus primarily targets cells with high metabolic activity. To multiply, it hijacks the energy and products provided by the cell.

This requirement constitutes a weakness for the virus and could be exploited to tackle infected cells. Scientists succeeded in blocking the infection ex vivo thanks to metabolic activity inhibitors that have already been investigated in cancer research.

"We have observed ex vivo that, thanks to certain metabolic inhibitors, the is no longer able to infect cells and amplification is halted in reservoirs of patients receiving antiretroviral treatment."

Explore further

HIV latency differs across tissues in the body

More information: José Carlos Valle-Casuso et al, Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection, Cell Metabolism (2018). DOI: 10.1016/j.cmet.2018.11.015
Journal information: Cell Metabolism

Provided by Pasteur Institute
Citation: AIDS—an approach for targeting HIV reservoirs (2018, December 21) retrieved 11 May 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments